Disclosure of elevated amyloid status is not associated with long-term suicidality in a preclinical AD trial. Grill JD, Raman R, Flournoy C, Ernstrom K, et al. Alzheimers Dement 2025;21:e14623.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Grill JD, Raman R, Flournoy C, Ernstrom K, et al. Disclosure of elevated amyloid status is not associated with long-term suicidality in a preclinical AD trial. Alzheimers Dement 2025;21:e14623.
PMID: 39988989